Annabella – the first breast pump to simulate a baby’s tongue, was launched in Israel, taking an estimated 10% of the monthly Israeli breast pump market, in February. The...
TEL AVIV, Israel, March 13, 2023 /PRNewswire/ -- Annabella, the world's first breast pump to simulate a baby's tongue during the pumping process, was recently launched in Israel after five years of development. The Annabella made its market debut on February 16, 2023, and quickly captured an estimated 10% share of the monthly sales in the Israeli breast pump...
Revitalize Beauty Through Science: Skincare Tech Brand AMIRO Unveils Its All-In-One LED Light Therapy Face Mask
SHENZHEN, China, Jan. 20, 2023 /PRNewswire/ -- Tech-centric beauty brand AMIRO has just unveiled its latest skincare device, the AMIRO L1 LED Light Therapy Face Mask, as a response to consumer demand. AMIRO L1 LED Light Therapy Face Mask The anti-aging LED face mask is built to emit four wavelengths of light for...
OMRON Healthcare’s Smart Devices Help Detect Early Heart Failure Risks in Over 33% of Study Participants
- Pilot Project on Home-based Heart Failure ICT Monitoring -- Using Vital Data to Enable Early Medical Intervention - KYOTO, Japan, July 31, 2025 /PRNewswire/ -- OMRON Healthcare Co., Ltd., the world's leading manufacturer and distributor of personal heart health products, has successfully concluded a three-month study demonstrating how remotely monitored vital signs can facilitate early medical intervention...
TCM provides new alternatives for the fight against COVID-19
BEIJING, Dec. 22, 2021 /PRNewswire/ -- A news report by haiwainet.cn: During the 18th World Congress of Traditional Chinese Medicine held on 4 December 2021, experts from Spain, France, Australia and other countries and regions highly recognized the role of Traditional Chinese Medicine (TCM) in fighting against COVID-19. Dr. Chen Zhen, President of the Central and Eastern European Federation...
Shanghai Public Health Clinical Center Completed Patient Enrollment in Clinical Study of PD-L1 Antibody ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV Infection
HANGZHOU and SHAOXING, China, Sept. 15, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that the clinical study of PD-L1 antibody ASC22 (Envafolimab) in combination with Chidamide for functional cure of human immunodeficiency virus (HIV) infection has completed the enrollment of 15 HIV infected patients. The objective of this study (ClinicalTrials.gov Identifier: NCT05129189) is to evaluate...
Nuance Pharma Announces Clearance of IND Application for Ensifentrine Pivotal Clinical Trials for COPD in China
SHANGHAI, Aug. 19, 2022 /PRNewswire/ -- Nuance Pharma ("the Company") announces the Center for Drug Evaluation ("CDE") has approved its Investigational New Drug ("IND") application supporting its pivotal clinical trial of Ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease ("COPD") in mainland China. Ensifentrine is a first-in-class, dual inhibitor of the enzymes phosphodiesterase 3 and 4 ("PDE3" and "PDE4")...
Molecular Diagnostics Developer INEX Innovate Announces Funding for New Research with The Chinese University of Hong Kong
Singapore-based diagnostics developer INEX Innovate brings The Chinese University of Hong Kong together to further research work on LEXI®, INEX's fetal cell based non-invasive pre-natal diagnostics technology. SINGAPORE, July 26, 2022 /PRNewswire/ -- Singapore-based diagnostics developer and medical laboratory operator, INEX Innovate has contributed an undisclosed sum to leading Hong Kong university...
Actinogen to present progress on Phase 2 trials at the BIO Investor Forum, San Francisco and Clinical Trials on Alzheimer’s Disease (CTAD) Conference, Boston
Xanamem® is an oral, brain-penetrant tissue cortisol synthesis inhibitor that has shown promising safety and clinical activity in three placebo-controlled trials and has the potential to treat a variety of neurodegenerative and neuropsychiatric diseases SYDNEY, Oct. 13, 2023 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) CEO Dr Steven Gourlay will conduct a series...
CStone presents research data of CS5001 (ROR1 ADC) at the 33rd AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021
SUZHOU, China, Oct. 8, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the data on the preclinical characterization of the potentially global best-in-class drug CS5001(ROR1 ADC) was accepted in a late-breaking abstract (LBA) session as a virtual poster presentation...
Mediballoon’s Online Shop is now live, offering a range of medical balloons and tubing for sale. Mediballoon is your best partner for medical device development.
UNION CITY, Calif., Aug. 9, 2023 /PRNewswire/ -- Mediballoon, Inc., a Medeologix company established in 2016 specializing in medical balloon design, development, and scale-up production, is excited to announce the launch of the Mediballoon Online Shop. This newly unveiled platform caters to engineers, designers, and innovators seeking to rapidly prove their concepts in advanced medical devices, by offering a...
